Donald W. Joseph
Founder at Sorbent Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Healy | M | 59 |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Randall E. Woods | M | 72 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | 12 years |
| Scott Minick | M | 72 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Markus Goebel | M | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Clare Trachtman | F | - | 24 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harry Kraemer | M | 69 | 11 years | |
| William B. Graham | M | - | 40 years | |
| Lee W. Henderson | M | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| William R. Rajski | M | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Lester Knight | M | 65 | 15 years | |
| Dean Abrassart | M | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Marla Persky | F | 68 | 19 years | |
| Thomas O'Neil | M | 59 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Robert Hombach | M | 58 | 26 years | |
| Gregory Paul Watson | M | 68 | 12 years | |
| James Tobin | M | 79 | 22 years | |
| Brian Anderson | M | 73 | 13 years | |
| Walter E. Boomer | M | 85 | - | |
| Phillip L. Batchelor | M | 62 | - | |
| Thomas T. Stallkamp | M | 77 | 22 years | |
| Karen May | F | 65 | 15 years | |
| Fabrizio Bonanni | M | 78 | 25 years | |
| Steven J. Meyer | M | 67 | 7 years | |
| Rick Wallace | M | - | 10 years | |
| Kathryn A. Tunstall | F | 73 | 7 years | |
| Brent Hatzis-Schoch | M | 59 | 4 years | |
| Fredric I. Orkin | M | - | 7 years | |
| Terry N. Layton | M | - | 2 years | |
| Dwight Mater | M | - | 6 years | |
| Robert Peterson | M | 67 | 13 years | |
| Paul G. Marshall | M | 64 | 6 years | |
| Toni L. Wayne | F | 71 | 8 years | |
| Ronald H. Abrahams | M | - | 4 years | |
| Jacqueline Kunzler | M | 58 | - | |
| Richard Epstein | M | - | 6 years | |
| Carlos Alonso Marum | M | - | - | |
| David Collier | M | 61 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Nicholas A. Loiacono | M | 71 | 3 years | |
| Timothy Bruce Anderson | M | 77 | 30 years | |
| Todd F. Davenport | M | 73 | 2 years | |
| Mary Ladone | F | 57 | 16 years | |
| Steven C. Collins | M | - | 5 years | |
| Linda Ara | F | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Michael Griffith | M | - | 13 years | |
| Michael Shapiro | M | 53 | - | |
| Julie Iwashita | F | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | 3 years |
| Kim Brady | M | 60 | 4 years | |
| Bee-Yau Huang | F | - | - | |
| William Waddill | M | 67 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Nancy A. Krejsa | F | 66 | 14 years | |
| Carsten Brockmeyer | M | - | 7 years | |
| Satinder K. Sethi | M | - | - | |
| Björk Tórarinsdóttir | M | - | 5 years | |
| Jason D. Levin | M | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Kent Stemper | M | - | 13 years | |
| Peter Rhode | M | 66 | 5 years | |
| Tom H. Quinn | M | 76 | 2 years | |
| Hing Wong | M | 70 | 4 years | |
| Thomas Keuer | M | 65 | 6 years | |
| John W. Colloton | M | 93 | 14 years | |
| Tony White | M | 77 | 9 years | |
| John Weiland | M | 68 | 1 years | |
| Joseph G. Darling | M | 66 | 6 years | |
| Robert J. Deans | M | 71 | 6 years | |
| Obi Greenman | M | 57 | 4 years | |
| William E. Saxelby | M | 67 | 21 years | |
| Ramon M. Perez | M | 70 | 16 years | |
| John H. Kehl | M | 70 | - | |
| Bill Gantz | M | 86 | 26 years | |
| John F. Gaither | M | 74 | 18 years | |
| Randel Woodgrift | M | 62 | 14 years | |
| Gregory P. Young | M | 70 | - | |
| Thomas Sabatino | M | 65 | 14 years | |
| Jan Reed | F | 64 | 6 years | |
| James Michael Gatling | M | 74 | - | |
| Vernon R. Loucks | M | 89 | 33 years | |
| Victor M. G. Chaltiel | M | - | - | |
| Michael Mussallem | M | 71 | 21 years | |
| Timothy J. Wollaeger | M | 80 | 8 years | |
| John A. Bardis | M | 67 | 9 years | |
| Martin Emerson | M | 60 | 12 years | |
| R. Huennekens | M | 59 | 4 years | |
| Michael Peter Short | M | - | 10 years | |
| Andrew Cleeland | M | - | 2 years | |
| Robert Zollars | M | 66 | 11 years | |
| Phillip Charles Henderson | M | 83 | 7 years | |
| Giovanni A. Ferrara | M | 55 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | 2 years |
| A. Peter Lawson | M | 77 | 2 years | |
| John Steven Sonnier | M | - | - | |
| Clifford A. Hewitt | M | - | 1 years | |
| Terrence J. Mulligan | M | 78 | 26 years | |
| Stephen Hoffman | M | 70 | 3 years | |
| Sam Leno | M | 78 | 23 years | |
| Howard C. Dittrich | M | 71 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | 2 years |
| Norbert Riedel | M | 66 | 15 years | |
| Jay Shepard | M | 66 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Donald Middlebrook | M | 73 | 15 years | |
| Stephen D. Chubb | M | 80 | 2 years | |
| Peter Farrell | M | 81 | 5 years | |
| Sharon Luboff | F | - | 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Donald W. Joseph
- Personal Network
